Melinda S. Hendrix

Melinda Hendrix practices at Wabash Valley Health Center in Terre Haute, Indiana.

Melinda Hendrix's NPI, 1114391281, was assigned on November 30, 2015. Melinda Hendrix holds Indiana license 71006242A.

Melinda Hendrix's primary practice is Wabash Valley Health Center, at 1436 Locust St, Terre Haute, IN 47807 in Vigo County. The practice phone is (317) 713-7947.

Melinda Hendrix's primary practice is Wabash Valley Health Center in Terre Haute, Indiana. Melinda Hendrix is also affiliated with Union Hospital. The medical group on file is Wabash Valley Health Center. Dmand AI also links Melinda Hendrix to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Melinda Hendrix's employer is on file too: a community health center (fqhc).

Dmand AI tracks the electronic health record (EHR) system at each site where Melinda Hendrix practices, 5 sites in all. Vendor and product names are available with a free account.

Family is Melinda Hendrix's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Melinda Hendrix is licensed in Indiana.

CMS counts 33 Medicare patients who saw Melinda Hendrix in 2024. The largest group is under 65, with 15 patients. 73% of them have high blood pressure, and 67% have high cholesterol. 58% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Melinda Hendrix's median patient age at 57, with 62% women.

In 2024, Melinda Hendrix wrote 2,815 Medicare Part D claims for 246 patients. 84% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Melinda Hendrix for performance year 2024, reported through an alternative payment model (APM). Melinda Hendrix accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Melinda Hendrix from 5 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Phathom Pharmaceuticals, Inc. paid the most, $21.